Top

Internal and Emergency Medicine

Published in:

17-06-2022 | Insulins | CE-Research Letter to the Editor

Discontinuation of low-dose thiazide treatment in hypertensive patients associated with improvement in glycemic profile

Authors: Alberto Preda, Angelo Semeraro, Giorgio Fiore, Luca Liberale, Fabrizio Montecucco, Gabriele Fragasso

Published in: Internal and Emergency Medicine | Issue 6/2022

Excerpt

Dear Editor, …

Whelton PK et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension 71:e13–e115. https://doi.org/10.1161/hyp.0000000000000065CrossRefPubMed

Williams B et al (2018) 2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. Blood Press 27:314–340. https://doi.org/10.1080/08037051.2018.1527177CrossRefPubMed

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Am Med Assoc 288:2981–2997. https://doi.org/10.1001/jama.288.23.2981CrossRef

Ellison DH, Loffing J (2009) Thiazide effects and adverse effects. Hypertension 54:196–202. https://doi.org/10.1161/HYPERTENSIONAHA.109.129171CrossRefPubMed

Lithell HO (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14:203–209. https://doi.org/10.2337/diacare.14.3.203CrossRefPubMed

Suchard MA et al (2019) Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. The Lancet 394:1816–1826. https://doi.org/10.1016/s0140-6736(19)32317-7CrossRef

Hall JJ, Eurich DT, Nagy D, Tjosvold L, Gamble JM (2020) Thiazide diuretic-induced change in fasting plasma glucose: a meta-analysis of randomized clinical trials. J Gen Intern Med 35:1849–1860. https://doi.org/10.1007/s11606-020-05731-3CrossRefPubMedPubMedCentral

Musini VM, Nazer M, Bassett K, Wright JM (2014) Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003824.pub2CrossRefPubMed

Lin JJ, Chang HC, Ku CT, Chen HY (2016) Hydrochlorothiazide hypertension treatment induced metabolic effects in type 2 diabetes: a meta-analysis of parallel-design RCTs. Eur Rev Med Pharmacol Sci 20:2926–2934PubMed

10.

Zhang X, Zhao Q (2016) Association of thiazide-type diuretics with glycemic changes in hypertensive patients: a systematic review and meta-analysis of randomized controlled clinical trials. J Clin Hypertens 18:342–351. https://doi.org/10.1111/jch.12679CrossRef

11.

Hollander W, Wilkins RW (1957) Chlorothiazide: a new type of drug for the treatment of arterial hypertension. BMQ 8:69–75PubMed

12.

Zatuchni J, Kordasz F (1961) The diabetogenic effect of thiazide diuretics. Am J Cardiol 7:565–567. https://doi.org/10.1016/0002-9149(61)90513-6CrossRefPubMed

13.

Shah SJ, Stafford RS (2017) Current trends of hypertension treatment in the United States. Am J Hypertens 30:1008–1014. https://doi.org/10.1093/ajh/hpx085CrossRefPubMedPubMedCentral

14.

Tsujimoto T, Kajio H (2019) Thiazide use and cardiovascular events in type 2 diabetic patients with well-controlled blood pressure. Hypertension 74:1541–1550. https://doi.org/10.1161/HYPERTENSIONAHA.119.13886CrossRefPubMed

Title: Discontinuation of low-dose thiazide treatment in hypertensive patients associated with improvement in glycemic profile
Authors: Alberto Preda
Angelo Semeraro
Giorgio Fiore
Luca Liberale
Fabrizio Montecucco
Gabriele Fragasso
Publication date: 17-06-2022
Publisher: Springer International Publishing
Keywords: Insulins
Diuretics
Hydrochlorothiazide
Insulins
Published in: Internal and Emergency Medicine / Issue 6/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-022-03030-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2022

Use of antibiotics in respiratory viral infections

Effect of a pulmonary embolism diagnostic strategy on clinical outcomes in patients hospitalized for COPD exacerbations

Correction to: Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up

What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence

High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19

Outcomes of a resident-led ultrasound-guided peripheral intravenous catheter placement training program and validation of a procedural training checklist

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials